| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/01/2011 | US20110212122 Nerve Growth Factor Conjugates and Uses Thereof |
| 09/01/2011 | US20110212099 Methods of modulating il-22 and il-17 |
| 09/01/2011 | US20110212094 Dual variable domain immunoglobulins and uses thereof |
| 09/01/2011 | US20110212087 Antibody Fc Mutants with Ablated Effector Functions |
| 09/01/2011 | US20110212077 Bi-aryl meta-pyrimidine inhibitors of kinases |
| 09/01/2011 | US20110212053 Phosphatidylinositol 3 kinase inhibitors |
| 09/01/2011 | US20110212052 Methods and compositions of treating and preventing autoimmune diseases |
| 09/01/2011 | US20110212051 Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
| 09/01/2011 | CA2790199A1 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 08/31/2011 | EP2361253A1 Compounds |
| 08/31/2011 | EP2361251A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/31/2011 | EP2361243A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 08/31/2011 | EP2231676B1 (e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo-[a,d]-cyclohepten-5-ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis |
| 08/31/2011 | EP2214659B1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 08/31/2011 | EP2183027B1 Organic compounds |
| 08/31/2011 | EP2031057B1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 08/31/2011 | EP1401498B1 Anti-ngf antibodies for the treatment of various disorders |
| 08/31/2011 | CN201949221U 一种活血通络止痛的远红外穴位贴 One kind of pain Huoxuetongluo far infrared acupoint paste |
| 08/31/2011 | CN201948563U 杜仲颈椎保健枕 Gutta Cervical Pillow |
| 08/31/2011 | CN1895242B Diclofenac salt pleximetric paste and its production |
| 08/31/2011 | CN102171329A Lactic acid bacterium having high oxalic acid decomposition ability |
| 08/31/2011 | CN102171249A Long-acting interferons and derivatives thereof and methods thereof |
| 08/31/2011 | CN102171204A 8-substituted isoquinoline derivative and use thereof |
| 08/31/2011 | CN102171196A Oxazole derivatives useful as inhibitors of FAAH |
| 08/31/2011 | CN102170905A Therapeutic agent or preventive agent for osteoarthritis |
| 08/31/2011 | CN102170872A Method of modulating membrane potential of a cell |
| 08/31/2011 | CN102168074A Recombinant adenovirus and application thereof |
| 08/31/2011 | CN102167741A Fully human anti-TNF-alpha (Tumor Necrosis Factor-alpha) monoclonal antibody and preparation method as well as application thereof |
| 08/31/2011 | CN102167720A Betulonic acid derivant for restraining differentiation of osteoclast, preparation method thereof and application thereof |
| 08/31/2011 | CN102167714A Quick and efficient method for preparing glucosamine sulfate potassium chloride compound salt |
| 08/31/2011 | CN102166343A Medicine for treating fracture and caput femoris necrosis and preparation method thereof |
| 08/31/2011 | CN102166333A Chinese medicine composition for treating caput femoris necrosis |
| 08/31/2011 | CN102166318A Chinese medicated wine for treating rheumatoid disease |
| 08/31/2011 | CN102166302A Metabolism-compensation method for treating rheumatic osteoarthritis and proportioning and preparing process of preparation thereof |
| 08/31/2011 | CN102166287A Recovery mud moxibustion and preparation method |
| 08/31/2011 | CN102166286A Medicine for treating osteoporosis |
| 08/31/2011 | CN102166278A Chinese medicinal composition for treating pediatric rheumatoid arthritis and preparation method thereof |
| 08/31/2011 | CN102166273A Bone spur medicine |
| 08/31/2011 | CN102166263A Compound preparation for treating cervical spondylotic myelopathy and preparation method thereof |
| 08/31/2011 | CN102166246A Oil-in-water type atractylis oil nano emulsion oral liquid |
| 08/31/2011 | CN102166236A Oil-in-water type notopterygium oil nano emulsion oral liquid and preparation method thereof |
| 08/31/2011 | CN102166229A Traditional Chinese medicine external preparation and method of processing same |
| 08/31/2011 | CN102166212A Method for making benidipine hydrochloride quickly dissolved from tablets |
| 08/31/2011 | CN102166204A Pharmaceutical composition for preventing and/or treating bone loss |
| 08/31/2011 | CN101953941B Chinese medicinal liquor for treating femoral head necrosis |
| 08/31/2011 | CN101904922B Plaster for treating pain caused by femoral head necrosis |
| 08/31/2011 | CN101890122B Medicament for treating bone diseases |
| 08/31/2011 | CN101850076B External medicament for treating arthralgia and preparation method thereof |
| 08/31/2011 | CN101850011B External medicament for treating cervical spondylosis and preparation method thereof |
| 08/31/2011 | CN101843691B Chinese medicament for treating femoral head necrosis |
| 08/31/2011 | CN101797293B Chinese medicinal pillow core for treating cervical spondylosis and preparation method thereof |
| 08/31/2011 | CN101698020B Traditional Chinese medicine preparation for treating femoral head necrosis and preparation method thereof |
| 08/31/2011 | CN101601662B Alendronate sodium intestine-sol capsule and preparation method thereof |
| 08/31/2011 | CN101579389B Medicinal composition for treating osteoporosis |
| 08/31/2011 | CN101564474B Foot soaking preparation for treating gout and preparation method thereof |
| 08/31/2011 | CN101480456B Pharmaceutical composition for treating rheumatism and heumatism and preparation method thereof |
| 08/31/2011 | CN101444552B Chinese medicinal preparation for treating osteoporosis |
| 08/31/2011 | CN101401939B Anti-activated state T cell antibody vaccine for preventing and/or treating immune correlated disease |
| 08/31/2011 | CN101322756B Medicament for massaging and treating lumbar disease and preparation thereof |
| 08/31/2011 | CN101306170B Traditional Chinese medicinal preparation for fracture setting |
| 08/31/2011 | CN101209337B Medicinal liquor for treating rheumatism and rheumatoid |
| 08/30/2011 | US8008433 Methods for preventing or treating bone disorders |
| 08/30/2011 | US8008321 Imidazo[1,5-a]pyridin-3-yl)(3-methoxy-4-nitrophenyl)methanone; a and b fibroblast growth factor receptors (FGFR) antagonist; anticarcinogenic, antitumor: lung, breast, prostate, melanomas, gliomas; antiinflammatory, vascular smooth muscle cells: atherosclerosis, restenosis, stent and bypass complications |
| 08/30/2011 | US8008308 Phosphonate compounds |
| 08/30/2011 | US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 08/30/2011 | US8007817 Compositions and methods for treating microbial infections |
| 08/30/2011 | US8007799 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | US8007752 Process for preparing oral calcium compositions |
| 08/30/2011 | CA2440473C Metalloproteinase inhibitors |
| 08/30/2011 | CA2425145C Methods of treatment using wisp polypeptides |
| 08/30/2011 | CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 08/30/2011 | CA2393352C Adamantane derivatives |
| 08/30/2011 | CA2372150C Therapeutic applications of pro-apoptotic benzodiazepines |
| 08/25/2011 | WO2011103134A1 Aminothiazolones as estrogen related receptor-alpha modulators |
| 08/25/2011 | WO2011102684A2 Composition containing placenta extracts |
| 08/25/2011 | WO2011102436A1 Tgf-β signal transduction inhibitor |
| 08/25/2011 | WO2011102404A1 Imidazole derivative |
| 08/25/2011 | WO2011102310A1 Blood uric acid level lowering agent |
| 08/25/2011 | WO2011101806A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors |
| 08/25/2011 | WO2011101644A1 Triazolo [4, 5 - b] pyridin derivatives |
| 08/25/2011 | WO2011100983A1 Casein, a novel curcumin drug carrier system |
| 08/25/2011 | WO2011066880A3 Pasteurised and fermented dairy product supplemented with calcium and vitamin d and procedure for preparing such product |
| 08/25/2011 | WO2011046964A3 Inhibitors of bruton's tyrosine kinase |
| 08/25/2011 | WO2011046599A9 Treatment and prognosis with thalidomide in multiple myeloma based on karyotyping and gene expression profiling |
| 08/25/2011 | WO2011039338A3 Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases |
| 08/25/2011 | WO2011028062A3 Composition for increasing height |
| 08/25/2011 | WO2011008773A3 Mesenchymal stem cell differentiation |
| 08/25/2011 | US20110209227 Methods for the diagnosis and treatment of bone disorders |
| 08/25/2011 | US20110208673 Antibodies to lymphotoxin-alpha |
| 08/25/2011 | US20110207825 Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics |
| 08/25/2011 | US20110207785 2-Aryl-Propionic Acids and Derivatives and Pharmaceutical Compositions Containing Them |
| 08/25/2011 | US20110207746 New compounds i |
| 08/25/2011 | US20110207732 Azaindole derivatives |
| 08/25/2011 | US20110207726 Inhibitors of Human Cathepsin L, Cathepsin B, and Cathepsin S |
| 08/25/2011 | US20110207713 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE |
| 08/25/2011 | US20110207711 Therapeutic Compounds |
| 08/25/2011 | US20110207704 Novel Oxadiazole Compounds |
| 08/25/2011 | US20110207679 Methods of treatment using il-16 antagonist peptides |
| 08/25/2011 | US20110207666 Method of promoting bone growth with hyaluronic acid and growth factors |